Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.molecularpartners.com/molecular-partners-provides-regulatory-update-of-european-and-japanese-filings-of-abicipar-pegol/

MOLECULARPARTNERS
20 Jul 2020

https://eyewire.news/articles/allergan-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol/

EYEWIRE
29 Jun 2020

https://uk.reuters.com/article/us-molecular-prtnrs-abbvie-eye-drug/molecular-partnerss-abbvie-partnered-eye-drug-gets-fda-safety-snub-idUKKBN23X0WG

John Miller REUTERS
26 Jun 2020

https://www.prnewswire.com/news-releases/allergan-an-abbvie-company-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol-301084188.html

PRNEWSWIRE
26 Jun 2020

https://www.biospace.com/article/releases/allergan-and-molecular-partners-present-late-breaking-data-from-phase-3-studies-of-investigational-abicipar-pegol-in-neovascular-wet-age-related-macular-degeneration/?s=95

BIOSPACE
15 Oct 2019

https://www.prnewswire.com/news-releases/allergan-and-molecular-partners-announce-topline-safety-results-from-maple-study-of-abicipar-pegol-300822353.html

PR NEWSWIRE
02 Apr 2019